Adeptio Pharmaceuticals Limited
- Address
- Suite1 7th Floor, 50 Broadway
Sponsor Overview
Specializations
Dermatological Therapeutics
The sponsor demonstrates a concentrated interest in developing treatments for dermatological conditions, with particular attention to inflammatory and immune-mediated skin disorders. The research portfolio reflects a commitment to addressing conditions that significantly impact patients' quality of life through visible symptoms and chronic disease burden.
- Atopic Dermatitis and Eczematous Conditions
- Inflammatory Skin Disease Management
- Chronic Dermatological Disorders
The therapeutic development programme encompasses investigations into novel approaches for managing persistent skin conditions, focusing on patients who experience moderate to severe manifestations of inflammatory dermatoses. The research extends to understanding the underlying pathophysiology of skin barrier dysfunction and immune dysregulation in affected populations.
Immunological and Inflammatory Disease Research
A significant area of focus involves the development of interventions targeting immune-mediated inflammatory pathways. The sponsor's research activities demonstrate particular interest in conditions where dysregulated immune responses contribute to chronic tissue inflammation and patient morbidity.
- Immune System Modulation
- Chronic Inflammatory Disease States
- Cytokine-Mediated Pathology
The therapeutic strategy appears oriented toward addressing the complex interplay between innate and adaptive immunity in chronic inflammatory conditions, with emphasis on developing targeted interventions that may offer improved efficacy and safety profiles for patients with persistent immune-related disorders.
Paediatric and Adolescent Medicine
The research portfolio includes dedicated attention to conditions affecting younger patient populations, reflecting recognition of the unique therapeutic needs in paediatric dermatology and related fields. This focus addresses the particular challenges of managing chronic conditions that manifest during childhood and adolescence.
- Paediatric Inflammatory Skin Conditions
- Adolescent Dermatological Health
- Age-Specific Treatment Approaches
The developmental programme encompasses investigations appropriate for younger age groups, acknowledging the distinct physiological, psychological, and developmental considerations required when treating chronic inflammatory conditions in children and adolescents. This includes attention to long-term disease management strategies that can be sustained throughout critical growth and development periods.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of (+)-α-Dihydrotetrabenazine Efficacy in Moderate to Severe Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled Study |  Czechia Hungary Poland Slovakia | Recruiting |
| Phase 2 Study of (+)-α-Dihydrotetrabenazine for Tardive Dyskinesia in Schizophrenia, Schizoaffective, Mood, Gastrointestinal, or Neuroleptic-Induced Disorders |  Croatia | Not Yet Recruiting |
| Safety Evaluation of Long-Term Maintenance Therapy with (+)-α-Dihydrotetrabenazine in Patients with Moderate to Severe Tardive Dyskinesia | Czechia Poland | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 12 sites across their trial portfolio.
Therapeutic Focus
- 1.Nervous System Diseases3 trials449 other sponsors
Partnered Research Centres
12 centres- Address
- Sumavska 2, Vychodni Predmesti, 301 00 Pilsen
- Address
- Nyiri Ut 38, 6000 Kecskemét
- Address
- Europska Avenija 14, 31000 Osijek
- Address
- Počernická 1427/16, 100 00 Prague
- Address
- Krizikova 264/22, Karlin, 186 00 Prague
- Address
- Ulica Mije Kispatica 12, 10000 Zagreb
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Adeptio Pharmaceuticals Limited.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.